Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 182.75
+6.80 (3.86%)
At close: Feb 20, 2026
Sartorius Stedim Biotech Revenue
In the year 2025, Sartorius Stedim Biotech had annual revenue of 2.97B EUR with 6.74% growth. Sartorius Stedim Biotech had revenue of 772.20M in the quarter ending December 31, 2025, with 2.78% growth.
Revenue
2.97B
Revenue Growth
+6.74%
P/S Ratio
5.99
Revenue / Employee
296.48K
Employees
10,134
Market Cap
17.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.97B | 187.50M | 6.74% |
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Eurofins Scientific SE | 7.30B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Ipsen | 3.93B |
Sartorius Stedim Biotech News
- 6 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 19 days ago - Sartorius Stedim Biotech SA (SDMHF) Q4 2025 Earnings Call Highlights: Strong Profit Growth and ... - GuruFocus
- 19 days ago - Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Preliminary Q4 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 19 days ago - Sartorius Stedim Biotech S.A. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 19 days ago - Sartorius Stedim Biotech FY25 Results Climb; Sees Growth In FY26, Beyond - Nasdaq
- 19 days ago - Sartorius Stedim Biotech S.A. Non-GAAP EPS of €4.40, revenue of €2.97B; initates FY26 outlook - Seeking Alpha
- 4 months ago - Q3 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus